Trademark: 97500212
Word
XENVERZY
Status
Pending
Status Code
731
Status Date
Thursday, August 1, 2024
Serial Number
97500212
Mark Type
4
Filing Date
Tuesday, July 12, 2022
Published for Opposition
Tuesday, June 6, 2023

Trademark Owner History
ZENTALIS PHARMACEUTICALS, INC. - Owner At Publication

Classifications
5 Pharmaceuticals, pharmaceutical preparations and substances for the prevention and treatment of cancer, auto-immune diseases, and infectious diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for the prevention and treatment of cancer, auto-immune diseases, and infectious diseases

Trademark Events
Jul 15, 2022
New Application Entered
Aug 2, 2022
New Application Office Supplied Data Entered
Apr 26, 2023
Assigned To Examiner
Apr 28, 2023
Approved For Pub - Principal Register
May 17, 2023
Notification Of Notice Of Publication E-Mailed
Jun 6, 2023
Published For Opposition
Jun 6, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 1, 2024
Sou Teas Extension Received
Feb 1, 2024
Sou Extension 1 Filed
Feb 1, 2024
Sou Extension 1 Granted
Aug 1, 2023
Noa E-Mailed - Sou Required From Applicant
Feb 3, 2024
Notice Of Approval Of Extension Request E-Mailed
Aug 1, 2024
Sou Teas Extension Received
Aug 1, 2024
Notice Of Approval Of Extension Request E-Mailed
Aug 1, 2024
Sou Extension 2 Filed
Aug 1, 2024
Sou Extension 2 Granted

Trademark Alertz updated from USPTO on 2030-01-24